Yuichi Iwaki

Fondatore presso MEDICINOVA, INC.

Patrimonio netto: 1 M $ in data 30/04/2024

74 anni

Consumer Services

Health Technology

Non-Energy Minerals

Posizioni attive di Yuichi Iwaki

Società	Posizione	Inizio	Fine
MEDICINOVA, INC.	Direttore/Membro del Consiglio	01/03/2007	-
	Amministratore Delegato	01/08/2005	-
	Fondatore	26/09/2000	-
	Presidente	01/03/2006	-
	Presidente	26/09/2000	01/03/2007
	Direttore Finanziario/CFO	22/04/2020	19/06/2020
Avigen, Inc. Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.	Amministratore Delegato	18/12/2009	-
	Direttore/Membro del Consiglio	01/11/1994	18/12/2009
University of South Carolina School of Medicine	Corporate Officer/Principal	01/01/1992	-
University of Southern California University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
University of Pittsburgh School of Medicine	Corporate Officer/Principal	01/01/1989	01/01/1991
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Direttore/Membro del Consiglio	-	-
AMCOL INTERNATIONAL CORPORATION	Presidente	-	-
AMCOL INTERNATIONAL CORPORATION	Presidente	-	-

Sapporo Medical University School of Medicine

Doctorate Degree

Distribuzione geografica

Stati Uniti	8
Giappone	2

Posizioni

Director/Board Member	3
Corporate Officer/Principal	3
Chief Executive Officer	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
MEDICINOVA, INC.	Health Technology

Aziende private	3
AMCOL International Corp. AMCOL International Corp. Construction MaterialsNon-Energy Minerals AMCOL International Corp. produces value-added, specialty minerals, and related product. The company was founded on December 30, 1959 and is headquartered in Hoffman Estates, IL.	Non-Energy Minerals
Avigen, Inc. Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.	Health Technology
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Health Technology